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Abstract The peptide tyrosine tyrosine (PYY) is pro-
duced and secreted from L cells of the gastrointestinal
mucosa. To study the anatomy and function of PYY-
secreting L cells, we developed a transgenic PYY-green
fluorescent protein mouse model. PYY-containing cells
exhibited green fluorescence under UV light and were
immunoreactive to antibodies against PYY and GLP-1
(glucagon-like peptide-1, an incretin hormone also secreted
by L cells). PYY-GFP cells from 15 lm thick sections were
imaged using confocal laser scanning microscopy and
three-dimensionally (3D) reconstructed. Results revealed
unique details of the anatomical differences between ileal
and colonic PYY-GFP cells. In ileal villi, the apical portion
of PYY cells makes minimal contact with the lumen of the
gut. Long pseudopod-like basal processes extend from
these cells and form an interface between the mucosal
epithelium and the lamina propria. Some basal processes
are up to 50 lm in length. Multiple processes can be seen
protruding from one cell and these often have a terminus
resembling a synapse that appears to interact with neigh-
boring cells. In colonic crypts, PYY-GFP cells adopt a
spindle-like shape and weave in between epithelial cells,
while maintaining contact with the lumen and lamina
propria. In both tissues, cytoplasmic granules containing
the hormones PYY and GLP-1 are confined to the base of
the cell, often filling the basal process. The anatomical
arrangement of these structures suggests a dual function as
a dock for receptors to survey absorbed nutrients and as a
launching platform for hormone secretion in a paracrine
fashion.
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Introduction
The hormone peptide tyrosine tyrosine (PYY) has been at
the forefront of obesity research based on its ability to
induce satiety and produce weight loss (Field et al. 2010).
PYY is synthesized as a 36 amino acid peptide (PYY1–36)
that is processed to a shorter form (PYY3–36), which
potently decreases appetite and reduces weight gain when
administered intravenously at physiological levels (Bat-
terham et al. 2002). The L cells of the gastrointestinal
mucosa secrete PYY in response to lipids (Greeley Jr et al.
1989) and amino acids and proteins (Zhang et al. 1993;
Batterham et al. 2006) present in the lumen of the gut.
Besides being a major signal of satiety, circulating PYY
has been shown to inhibit esophageal muscle contraction
(Huang 2000), delay gastric emptying (Savage et al. 1987),
inhibit jejunal and colonic motility (Lundberg et al. 1982),
act as a vasoconstrictor (Lundberg et al. 1982), and regu-
late renal sodium excretion (Playford et al. 1995). While
most of the attention has been focused on the physiological
effects of this hormone, relatively little is known about the
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biology of the PYY-secreting L cell. In 1982, Lundberg
et al. noticed that PYY immunoreactive cells occasionally
had long processes extending at their basal portion. How-
ever, the anatomy and function of these structures in the L
cell has yet to be described.
The study of these basal processes has been limited by
the fact that PYY antibodies bind primarily to granules
containing the hormone and do not delineate the entire
contour of the cell. Recently, Chandra et al. (2010) used a
transgenic CCK-green fluorescent protein (GFP) mouse
model to describe the structure of pseudopod-like basal cell
processes in intestinal cholecystokinin (CCK) cells. When
combined with confocal laser scanning microscopy
(CLSM), this model allowed for a detailed three-dimen-
sional reconstruction of GFP-positive cells. Hence, we
developed in our lab a transgenic PYY-GFP mouse model
to study PYY-secreting cells. During the course of this
work, we noticed that the anatomy of GFP-positive cells
and their basal processes vary depending on their location
along the intestinal tract. Moreover, the terminal end of the
basal processes often resembles a synapse that appears to
interact with other cells nearby. Therefore, the aim of the
present report was to describe the morphological charac-
teristics of basal processes in ileal and colonic PYY cells.
Materials and methods
Generation of transgenic PYY-GFP mouse
Bacteria artificial chromosome (BAC) clones, RP23-
291A19 and RP23-218N17, were obtained from the BAC
resource center at the Children’s Hospital Oakland Research
Institute (Oakland, CA, USA). Clones were characterized by
restriction enzyme digests run on pulse field gels and PCR.
An enhanced GFP DNA fragment was amplified from
pEGFP-N1 (Clontech Laboratories, Inc. Mountain View,
CA, USA) and the BGH polyadenylation sequence was
amplified from pcDNA3.1 (Invitrogen Corporation, Carls-
bad, CA, USA). The two PCR products were joined by
recombinant PCR (Higuchi 1990), and the EGFP-BGH
sequence was cloned into a pBluescript KS plasmid and
transformed into XL1 bacteria (Agilent Technologies, Santa
Clara, CA, USA). DNA from two bacterial colonies (pEGFP-
BGH/pBS) was sequenced in its entirety to identify clones
with no base pair errors. Subsequently, a neomycin cassette
FRT-Neo/Kan-FRT sequence was amplified by PCR from
the pIGCN21 plasmid (Lee et al. 2001). The PCR product
was digested with the appropriate restriction enzymes and
cloned downstream of the EGFP-BGH sequence in EGFP-
BGH/pBS. Homologous PYY arms were then amplified and
cloned into this vector as follows: 895 base pairs (bp) of PYY
sequence directly upstream of the start codon (A box) and
681 bp of PYY sequence directly downstream of the stop
codon (B box). The A box was cloned upstream of the EGFP-
BGH sequence and the B box was cloned downstream of the
FRT-Neo/Kan-FRT cassette. All PCR amplified DNA was
sequenced in its entirety on both strands. The PYY targeting
fragment cut 5’ of the A-Box and 3’ of the B-Box was
purified from the pBluescript plasmid.
BAC DNA was purified from DH10B bacterial cells and
transformed into SW105 bacteria. The BAC DNA from
SW105 cells was characterized by restriction digests run on
pulse field gels and PCR (of the PYY region) to verify the
integrity of the BAC. The PYY targeting fragment was
then electroporated into BAC-containing SW105 cells
induced for recombination by a temperature shift to 42C
for 15 min. Recombined BACs were selected with antibi-
otics and the neomycin cassette was removed by arabinose
induction of flipase expression. Recombined and neo
Table 1 Primary and secondary antibodies used in immunofluorescence analysis
Primary antibody Species Source Dilutiona Secondary antibody Source Dilution
PYY (aa 4–21) Rabbit Biosource 1:2,000 Cy3-conjugated donkey anti-rabbit Jackson ImmunoResearch 1:1,000
GFP Chicken Abcam 1:1,000 Dylight488-conjugated donkey anti-rabbit Jackson ImmunoResearch 1:1,000
PYY peptide tyrosine tyrosine, GFP green fluorescent protein
a All antibodies were diluted in 50 mM TRIS-buffered saline containing 0.05% Tween-20 and 0.1% bovine serum albumen
Fig. 1 Photomicrographs from colonic crypts. All sections are
aligned vertically with the lumen on top. White and black arrows
point to the lumen and lamina propria, respectively. Colors represent
the following: green green fluorescent protein (GFP), red PYY, blue
DAPI, and gray differential interference contrast (DIC) and are
merged from the left and middle columns. a–c Sections from wild
type Swiss Webster mice stained for GFP (a) and PYY (b). GFP is
absent and PYY cells appeared to have a spindle-like shape in the
colon of wild type mice. d–f Sections from PYY-GFP mice incubated
with secondary antibodies alone (DyLight488-conjugated donkey
anti-chicken and Cy3-conjugated donkey anti-rabbit). Colonic cells
from transgenic PYY-GFP mice expressed endogenous GFP and non-
specific binding of secondary antibodies was absent. g–i Sections
from a PYY-GFP mouse incubated in the presence of chicken anti-
GFP and rabbit anti-PYY pre-adsorbed in excess (10 lM) of PYY
peptide. The specificity of the antibody to PYY is shown by the
absence of immunoreactivy after pre-absorption with synthetic PYY.
j–l PYY-GFP sections incubated in the presence of chicken anti-GFP
and rabbit anti-PYY antibodies. PYY immunoreactivity with the
antibody exclusively co-localized with GFP positive cells (l, yellow).
Please refer to online version of the article for colored figures
c
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excised clones were again characterized by restriction
digests on pulse field gels and PCR. Verified BACs were
transferred to the Duke University Neurotransgenics
Facility, where BACs were linearized by Asc I and gel
purified. After filter dialysis, the BAC DNA concentration
was adjusted to 1 ng/ll and microinjected into the pronu-
clei of B6SJF1 mouse oocytes. Two independent founder
lines of PYY-GFP transgenic mice were generated; both
founders were derived from the EGFP construct cloned into
the RP23-218N17 BAC.
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The founder lines were bred in house at the Division of
Laboratory Animal Resources of Duke University School
of Medicine. Animals were raised in a 12 h light–12 h dark
cycle and had ad libitum access to feed and water. Animal
care and experiments were carried out in accordance with a
protocol approved by the Institutional Animal Care and
Use Committee of Duke University Medical Center.
Tissue collection
Tissue harvesting and PYY immunofluorescence were
carried out as described previously by Chandra et al.
(2010), with some modifications. Eight- to twelve-week-
old mice were anesthetized with a mixture of ketamine and
xylazine and perfused intracardially with ice-cold, freshly
depolymerized 3.5% paraformaldehyde (PFA) in phosphate
buffered saline (PBS, pH 7.4). Five centimeters of the
distal ileum (adjacent to the ileo-cecal junction) as well as
the entire colon (from the cecal junction to the anal canal)
were removed, flushed with PBS, and fixed in PFA for 3 h
at 4C. Tissues were cryo-protected sequentially in cold 10
and 20% sucrose in PBS, then incubated overnight at 4C
in 30% sucrose. The next day, smaller sections (*1 cm)
were embedded in molds containing Tissue-Tek OCT
compound (Sakura Finetek, Torrance, CA, USA) and rap-
idly frozen on dry ice for cryosectioning. Sections (15 lm
thick) were cut using a cryostat and mounted on positively
charged microscope slides (Globe Scientific Inc., Paramus,
NJ). The use of sections at least 15 lm thick was critical
for three-dimensional reconstruction of cells in the tissue.
Slides were air dried at room temperature for at least 1 h
before being stored at -80C.
PYY immunofluorescence
Antibodies used, suppliers, and antibody-specific staining
conditions are listed on Table 1. The PYY antibody was
raised in rabbits using a synthetic peptide, KPEAPGE-
DASPEELSRYC, corresponding to amino acids 4–21 of
mouse PYY, affinity-purified and characterized in our
laboratory. In general, slides were thawed at room
temperature for 30 min and post-fixed in 10% neutral
buffered formalin (NBF) for 10 min (4C). They were then
washed in 50 mM TRIS buffered saline containing 0.05%
Tween-20 (TBST) three times (5 min each). All washes
from this point forward were performed under the same
conditions unless otherwise stated. Non-specific binding
was blocked by incubation with 10% normal donkey serum
in PBS for 30 min. The serum was removed and sections
were incubated with the primary rabbit PYY antibody for
1 h. Slides were washed and sections were incubated with
the appropriate secondary antibody for 1 h. Finally, slides
were washed and counter-stained with 300 nM DAPI
(Invitrogen Corporation, Carlsbad, CA, USA). Cover slips
(# 1.5) were mounted using Prolong Gold anti-fade reagent
(Invitrogen Corporation, Carlsbad CA, USA). Control
sections included: a) wild-type mouse tissues treated with
PYY antibody to show PYY immunoreactive cells in their
native form; b) transgenic PYY-GFP mouse tissues treated
with secondary antibody alone to control for non-specific
binding; and c) transgenic PYY-GFP mouse tissues treated
with PYY antibody that was previously pre-adsorbed (24 h
at 4C) in 10 lM of PYY synthetic peptide to test for the
specificity of the antibody. Images from controls are pre-
sented in Fig. 1.
PYY and GLP-1 immunofluorescence
We used Tyramide Signal AmplificationTM (TSATM,
PerkinElmer, Waltham, MA, USA) to localize PYY and
GLP-1 in GFP-positive cells because the available anti-
bodies were both raised in rabbits. This method has been
previously reported for detection of peptides using anti-
bodies raised in the same species (Liu et al. 2006; Shindler
and Roth 1996). Table 2 contains a description of the
antibodies used, their source and incubation conditions for
TSATM amplification. Briefly, sections (15 lm thick) were
post-fixed in 10% NBF for 10 min (4C). They were then
incubated in 0.02 N HCl for 10 min to quench endogenous
peroxidase activity. Slides were washed and sections were
blocked for 1 h with normal donkey serum (1:10 in PBS),
followed by an overnight incubation (4C) with the first
Table 2 Antibodies used in immunofluorescence analysis with the Tyramide Signal Amplification (TSATM) method
Primary antibody Species Source Dilutiona Detection method Source Dilution
PYY (aa 4–21) Rabbit Biosource 1:1,000,000 HRP-conjugated donkey anti-rabbit Jackson ImmunoResearch 1:1,000
TSATM-Plus Cy5 PerkinElmer 1:200b
GLP-1 Rabbit Abcam 1:500 Cy3-conjugated donkey anti-rabbit Jackson ImmunoResearch 1:1,000
GFP Chicken Abcam 1:1,000 Dylight488-conjugated donkey anti-rabbit Jackson ImmunoResearch 1:1,000
PYY peptide tyrosine tyrosine, GLP-1 glucagon-like peptide 1, GFP green fluorescent protein
a All antibodies except for TSATM were diluted in 50 mM TRIS-buffered saline containing 0.05% Tween-20 and 0.1% bovine serum albumen
b TSATM-Cy5 reagent was diluted in 1X Plus Amplification Diluent provided with the TSATM kit (PerkinElmer, Waltham, MA)
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primary antibody (rabbit anti-PYY) at a dilution only
detectable by TSATM amplification. Sections were washed,
incubated for 1 h with peroxidase-conjugated anti-rabbit
secondary antibody, washed again and incubated for
20 min with TASTM-Cy5 amplifying reagent. Sections
were then washed and incubated for 1 h with the second
primary antibody (rabbit anti-GLP-1) and a chicken anti-
body against GFP. The GFP antibody was introduced to
prolong the duration of GFP signal while imaging a series
of Z-stacks. Slides were washed and sections were incu-
bated for 1 h with secondary antibodies anti-rabbit IgG
conjugated to Cy3 and anti-chicken IgG conjugated to
Dylight488. Finally, slides were washed, counterstained
with DAPI, and cover slips were mounted using mounting
Prolong Gold anti-fade reagent. Controls included sections
treated with rabbit anti-PYY and/or rabbit anti-GLP-1
without secondary antibody and sections treated with sec-
ondary antibody alone.
Fig. 2 Colocalization of PYY and glucagon-like peptide 1 (GLP-1)
in PYY-GFP cells of the ileum. a PYY staining (red) reveals
confinement of granules to the basal end of the PYY-GFP cell.
b GLP-1 staining (cyan) shows colocalization at the basal side of the
PYY-GFP cell. c Image overlay of PYY and GLP-1 granules
colocalized at the base of PYY-GFP cell (green GFP, red PYY, cyan
GLP-1 and white overlapping of PYY and GLP-1. Staining for PYY
(red) and GLP-1 (cyan) are projected as maximal intensities. Note
that not all PYY and GLP-1 staining colocalizes within the same
granules. This has been previously demonstrated by electron immu-
nogold staining (Nilsson et al. 1991). d Position of PYY-GFP cell
with respect to other cells of the epithelium (green GFP, blue DAPI
and gray DIC)
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Image acquisition and analysis
Samples were imaged on a Zeiss 510 inverted confocal
microscope using 20X/0.8 (Zeiss Plan Apochromat), 40X/
1.3 (Zeiss Plan NeoFluar) or 100X/1.4oil (Zeiss Plan
Apochromat) objectives. Single optical sections or Z-stacks
were obtained using sequential multi-track acquisition with
excitation at 405 (DAPI), 488 (eGFP or DyLight 488), 561
(Cy3), and 633 nm (TASTM-Cy5), and emission filters of
BP 420–480, BP505–550, LP575, and LP650. Pinholes
were set to 1 airy unit and line averaging of 8 at 1,024 pixel
resolution. Differential interference contrast (DIC) images
were also collected to determine the location of the cells
relative to the lumen. To visualize the images in 3D, Z-
stacks were deconvolved using Huygens Essential soft-
ware (BioVision Technologies, Exton, PA, USA) and
reconstructed in 3D using Volocity (PerkinElmer, Wal-
tham, MA, USA). Channels were visualized as: maximum
intensity projections (green/GFP, red/PYY, cyan/GLP-1),
which allow the channel’s color to be seen through other
channels or as fluorescence (blue/DAPI).
Results
Cells expressing enhanced GFP (eGFP), driven by the PYY
promoter, were immunoreactive with an antibody specific
to PYY (Fig. 1). Moreover, triple immunofluorescence
Fig. 3 Distribution of PYY-GFP cells in the ileum and colon.
Sections of ileum (a, c) and colon (b, d) from a PYY-GFP mouse
stained with chicken anti-GFP (a, b) and composite with DAPI nuclei
(blue) stain (c, d). PYY-GFP cells appear to be more abundant in the
colon than in the ileum. Note the spindle-like anatomy of PYY-GFP
cells in the colon compared to the L shape of those in the ileum
8 J Mol Hist (2011) 42:3–13
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staining for PYY, GLP-1, and GFP revealed colocalization
of PYY and GLP-1 within GFP-positive cells (Fig. 2).
PYY-GFP cells were observed from the pyloric region of
the gastric mucosa to the distal descending colon (data not
shown), though the vast majority were found in the distal
ileum and colon (Fig. 3). In both, the ileum and colon,
GFP-PYY cells were more abundant at the bottom of the
crypts than at the apex of the mucosa (e.g., villi in the
ileum). GFP expression was visible at around cell position
#3 counting from the bottom of the crypt. In this position in
both the ileum and colon, PYY-GFP cells were columnar in
shape and basal processes were short or absent (Fig. 4).
However, as the cells were observed further up from the
crypt base, their cell bodies adopted a flask-shape with a
long pseudopod-like structure extending from the bottom
of the cell (Fig. 4). From this point in the crypts, there
appeared unique anatomical differences between ileal and
colonic PYY-GFP cells.
PYY-GFP cells in the ileum had at least one process that
almost invariably extended from the cell base down toward
the bottom of the crypt (Figs. 4 and 5). Processes appeared
to form an interface between the base of the columnar
epithelial cells and the lamina propria. Some cells were
over 70 lm long with a basal process that reached up to 50
lm in length (Fig. 5). Many PYY-GFP cells had more than
one process (Fig. 6). The additional processes were often
visible at the base of the cell and extended away from the
direction of the crypt. Other processes were observed
protruding from the body of the cell towards other epi-
thelial cells (Fig. 6). Interestingly, the distal ends of some
processes resembled a synapse (Fig. 5e and 6). Occasion-
ally, such endings appeared to interact with unidentified
structures below the basal lamina and with other GFP-
positive cells in the epithelium (Fig. 6). However, they also
were found extending to GFP-negative epithelial cells.
In the colon, PYY-GFP cells at the apex of crypts
exhibited a spindle-like shape and their basal processes
were found in between other epithelial cells (Fig. 4). In this
way, one PYY-GFP cell can span more than 15 epithelial
cells lengthwise and still be exposed to the lumen of the
crypt and lamina propria at the same time (Fig. 7). Despite
the fact that the synapse-like endings appeared to be absent
in colonic PYY-GFP cells, some bifurcations were
observed but were fewer than those seen in the ileum (data
not shown).
Discussion
PYY has received recent attention in obesity research
because of its abilities to induce satiety and weight loss in
rodents and humans (Batterham et al. 2002; Batterham
et al. 2006). Although some of the effects of circulating
PYY have been well documented, relatively little is known
about the biology of the PYY-secreting L cell. Here we
report the use of a transgenic PYY-GFP mouse to study
Fig. 4 PYY-GFP cell morphology in the ileum versus colon. White
and black arrows indicate the lumen and lamina propria respectively.
a–c In the ileum a cells were columnar or flask-shaped at the bottom
of the crypts and pseudopod-like basal processes were absent. Further
up the crypt (b) towards the villus tip (c) basal processes became
evident. d–f In the colon, flask-shaped cells were evident at the
bottom of the crypts (d). A neck-like projection (black arrow head)
and a basal process were evident in the cell in the middle of the crypt
(e). Towards the apex of the crypt, this neck-like projection extended
to maintain contact with the lumen, while the basal process remained
in contact with the lamina propria (f). Note the sigmoidal appearance
of the cell to maintain contact with the lumen as well as the lamina
propria
J Mol Hist (2011) 42:3–13 9
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PYY cell anatomy in the distal gastrointestinal tract. In
agreement with previous reports on the localization of PYY
cells (El-Salhy et al. 1983), PYY-GFP cells were found
distributed along the gastrointestinal mucosa, predomi-
nantly in the ileum and colon. GFP-positive cells were
immunoreactive with PYY and GLP-1 antibodies, which is
typical of enteroendocrine L cells (Nilsson et al. 1991).
Cells expressing eGFP occasionally did not colocalize with
PYY antiserum, perhaps because eGFP can bleach during
the staining process and while imaging. To avoid such an
artifact, we used a chicken polyclonal antibody against
GFP (cGFP) previously described by Chandra et al. (2010).
Staining with cGFP clearly delineated the contour of PYY
cells and allowed enhanced visualization of their anatom-
ical characteristics.
PYY cells in the ileum appeared anatomically different
than those in the colon. The main difference is that mature
ileal PYY cells have a classic L-shape, whereas mature
Fig. 5 Pseudopod-like basal processes in PYY-GFP cells of the
ileum. White and red arrows indicate the lumen and lamina propria
respectively. Sections imaged were 15 lm thick. a Maximal projec-
tion view of typical PYY-GFP cell in a villus of the ileum. The
pseudopod-like process runs on the basal side, in between the lamina
propria and the base of other epithelial cells. The basal process
typically extends downward towards the bottom of the crypt. b–
d PYY-GFP cell with a long basal process extending along the base of
adjacent epithelial cells. The total length of the cell is greater than 70
lm and the basal process is approximately 50 lm long. b Green GFP,
c red PYY, d composite with DIC (gray). e Maximal projection view
of PYY-GFP cell in a villus from the ileum. Inset shows the cell
position with respect to the brush border (white arrow head) and
lamina propria (black arrow head) (green GFP, red PYY staining,
yellow merged images, gray DIC). The pseudopod-like basal process
often ended in a bifurcation (red arrow). There are some smaller
projections (red arrow head) that extended from the body of the cell
10 J Mol Hist (2011) 42:3–13
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colonic cells have a spindle- or sigmoidal-like contour. In the
ileum, the apical portion of these cells maintains minimal
contact with the gut lumen whereas in the colon the contact
with the lumen appears more prominent. PYY cells in both
the ileum and the colon have a long basal process running
underneath other epithelial cells. Although the existence of
Fig. 6 Relationship of a PYY-GFP cell with another PYY-GFP cell
through synapse-like structures at the end of pseudopod-like
processes. White and red arrows indicate the lumen and lamina
propria respectively. Section imaged was 15 lm thick. a–c Views of
three-dimensionally reconstructed PYY-GFP cells in a villus of the
ileum from different angles. The synapse-like projection at the end of
pseudopod-like process from cell 1 that makes contact with cell 2 is
shown by the white arrowhead. Green GFP, red PYY staining, yellow
merged images, blue DAPI
Fig. 7 Representation of PYY cells in the ileum versus colon. In the
ileum, PYY cells (L cells) are flask-shaped at the crypt whereas, in the
villus, a long pseudopod-like process extends at their base. The basal
processes usually extend toward the crypt. Occasionally, more than
one process can extend from the body of the cells toward other
epithelial cells. In the colon, PYY cells are flask-shaped at the bottom
of the crypt. However, at the apex of the crypt, PYY cells weave
through other epithelial cells and the tip of the cell runs along the
crypt’s lumen. The base of the same PYY cell runs vertically along
the crypt’s lamina propria. Whereas in the ileum PYY cells maintain
minimal contact with the gut lumen, in the colon PYY cells appear to
have a larger surface area exposed to the lumen
J Mol Hist (2011) 42:3–13 11
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basal processes in PYY cells has been recognized for decades
(Lundberg et al. 1982; Karaki et al. 2006), no anatomical or
functional description of these structures has been reported.
Studies in somatostatin cells have suggested that these ana-
tomical adaptations help to direct the paracrine secretion of
somatostatin onto neighboring gastrin cells (Alumets et al.
1979). In this way, somatostatin cells in the stomach can
regulate gastrin and hydrochloric acid secretion. Interest-
ingly, basal processes in somatostatin cells have been
described to end in bulb-like swellings (Alumets et al. 1979).
Our results also indicate that the processes in PYYGFP cells
end in bulb-like swellings that resemble synapses. We have
co-immunostained PYY-GFP sections with markers for
neuroendocrine (chromogranin A), goblet (intestinal trefoil-
factor-3) and enterochromaffin-like cells (serotonin) and
these cell types do not appear to be specific targets of the
PYY-GFP processes (data not shown). However, Wade and
Westfall (1985) have reported using electron microscopy
that basal processes in putative enteroendocrine cells are in
close proximity to neurites located below the basal lamina.
Therefore, basal processes in PYY-secreting cells may target
specific cell types located in the lamina propria.
Quantitative receptor autoradiography and immunohis-
tochemical studies have demonstrated the existence of PYY
receptors in the mucosa of the distal colon (Mannon et al.
1993; Jackerott and Larsson 1997; Mannon et al. 1999).
Hence, secreted PYY most likely influences adjacent cells
in a paracrine fashion. Electron microscopy and immuno-
histochemical studies have shown that enteroendocrine
cells including L cells, harbor their secretory granules at
their base (Cheng and Leblond 1974; Lundberg et al. 1982).
In agreement, our images showed that PYY immunoreac-
tivity is almost exclusively confined to the basal processes
of GFP-positive cells (Fig. 4). Moreover, triple immuno-
fluorescence staining with antibodies against GFP, PYY,
and GLP-1 revealed that both PYY and GLP-1 granules are
located at the basal end of GFP-positive cells (Fig. 2).
Feinle-Bisset et al. (2005) have shown that digestion of
ingested fats is necessary for lipid-mediated PYY secretion.
Hence, PYY secretion is likely mediated by receptors
activated by specific types of lipids. Recently, short chain
fatty acid receptors (e.g. GPR41, GPR43, GPR119) have
been shown to colocalize with PYY-secreting cells in
humans and rodents (Karaki et al. 2008; Karaki et al. 2006;
Coxsend et al. 2010). Moreover, the staining for these
receptors appears to be confined to the basal portion of PYY
cells (Karaki et al. 2008; Karaki et al. 2006). Hence, PYY
cell processes may serve a dual function: (1) as an anchor
for receptors to survey the passage of absorbed nutrients at
the base of enterocytes, and (2) as a launching platform to
direct the secretion of PYY into the bloodstream, neigh-
boring cells or specific targets in the lamina propria.
However, the specific functions and dynamics of these
structures remains to be elucidated.
In summary, the use of a transgenic PYY-GFP mouse
model provides unique anatomical details of the PYY-
secreting L cell, which are depicted in Fig. 7. GFP-positive
cells contained PYY and GLP-1, typical of the enteroen-
docrine L cell. The majority of PYY immunoreactivity was
colocalized at the base of the cells, often filling the basal
process. In the ileum, these cells had long extending basal
processes with terminal endings that resemble synapses.
More than one process could be observed protruding from
the body of the same cell. In the colon, the cells at the apex
of the crypt had a spindle-like shape that wove in between
epithelial cells while maintaining contact with both the
lumen and lamina propria. The unique anatomy and loca-
tion of the basal process in PYY-secreting cells may serve
to survey nutrient absorption and secrete hormone in an
endocrine and paracrine fashion.
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